{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HIV-1 capsid", "biolayer interferometry", "capsid assembly", "drug screening", "hexamer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37817748", "DateRevised": {"Year": "2023", "Month": "10", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "25"}], "Language": ["eng"], "ELocationID": ["1270258", "10.3389/fmicb.2023.1270258"], "Journal": {"ISSN": "1664-302X", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in microbiology", "ISOAbbreviation": "Front Microbiol"}, "ArticleTitle": "Modulation of HIV-1 capsid multimerization by sennoside A and sennoside B via interaction with the NTD/CTD interface in capsid hexamer.", "Pagination": {"StartPage": "1270258", "MedlinePgn": "1270258"}, "Abstract": {"AbstractText": ["Small molecules that bind to the pocket targeted by a peptide, termed capsid assembly inhibitor (CAI), have shown antiviral effects with unique mechanisms of action. We report the discovery of two natural compounds, sennoside A (SA) and sennoside B (SB), derived from medicinal plants that bind to this pocket in the C-terminal domain of capsid (CA CTD). Both SA and SB were identified via a drug-screening campaign that utilized a time-resolved fluorescence resonance energy transfer assay. They inhibited the HIV-1 CA CTD/CAI interaction at sub-micromolar concentrations of 0.18\u2009\u03bcM and 0.08\u2009\u03bcM, respectively. Mutation of key residues (including Tyr 169, Leu 211, Asn 183, and Glu 187) in the CA CTD decreased their binding affinity to the CA monomer, from 1.35-fold to 4.17-fold. Furthermore, both compounds induced CA assembly <i>in vitro</i> and bound directly to the CA hexamer, suggesting that they interact with CA beyond the CA CTD. Molecular docking showed that both compounds were bound to the N-terminal domain (NTD)/CTD interface between adjacent protomers within the CA hexamer. SA established a hydrogen-bonding network with residues N57, V59, Q63, K70, and N74 of CA1-NTD and Q179 of CA2-CTD. SB formed hydrogen bonds with the N53, N70, and N74 residues of CA1-NTD, and the A177and Q179 residues of CA2-CTD. Both compounds, acting as glue, can bring \u03b1H4 in the NTD and \u03b1H9 in the CTD of the NTD/CTD interface close to each other. Collectively, our research indicates that SA and SB, which enhance CA assembly, could serve as novel chemical tools to identify agents that modulate HIV-1 CA assembly. These natural compounds may potentially lead to the development of new antiviral therapies with unique mechanisms of action."], "CopyrightInformation": "Copyright \u00a9 2023 Zhang, Xu, Zhou and Fu."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China."}], "LastName": "Zhang", "ForeName": "Da-Wei", "Initials": "DW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China."}], "LastName": "Xu", "ForeName": "Xiao-Shuang", "Initials": "XS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}, {"Identifier": [], "Affiliation": "Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}], "LastName": "Zhou", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedics, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, China."}], "LastName": "Fu", "ForeName": "Zhiguo", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Microbiol", "NlmUniqueID": "101548977", "ISSNLinking": "1664-302X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdallah H. M., El-Halawany A. M., Sirwi A., El-Araby A. M., Mohamed G. A., Ibrahim S. R., et al. . (2021). Repurposing of some natural product isolates as SARS-COV-2 main protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches. Pharmaceuticals 14:213. doi: 10.3390/ph14030213", "ArticleIdList": ["10.3390/ph14030213", "PMC8001104", "33806331"]}, {"Citation": "Allers K., H\u00fctter G., Hofmann J., Loddenkemper C., Rieger K., Thiel E., et al. . (2011). Evidence for the cure of HIV infection by CCR5\u039432/\u039432 stem cell transplantation. Blood 117, 2791\u20132799. doi: 10.1182/blood-2010-09-309591, PMID:", "ArticleIdList": ["10.1182/blood-2010-09-309591", "21148083"]}, {"Citation": "Bartonova V., Igonet S., Sticht J., Glass B., Habermann A., Vaney M. C., et al. . (2008). Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein. J. Biol. Chem. 283, 32024\u201332033. doi: 10.1074/jbc.M804230200, PMID:", "ArticleIdList": ["10.1074/jbc.M804230200", "18772135"]}, {"Citation": "Bester S. M., Wei G., Zhao H., Adu-Ampratwum D., Iqbal N., Courouble V. V., et al. . (2020). Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science 370, 360\u2013364. doi: 10.1126/science.abb4808", "ArticleIdList": ["10.1126/science.abb4808", "PMC7831379", "33060363"]}, {"Citation": "Blair W. S., Pickford C., Irving S. L., Brown D. G., Anderson M., Bazin R., et al. . (2010). HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 6:e1001220. doi: 10.1371/journal.ppat.1001220, PMID:", "ArticleIdList": ["10.1371/journal.ppat.1001220", "PMC3000358", "21170360"]}, {"Citation": "Carnes S. K., Sheehan J. H., Aiken C. (2018). Inhibitors of the HIV-1 capsid, a target of opportunity. Curr. Opin. HIV AIDS 13, 359\u2013365. doi: 10.1097/COH.0000000000000472, PMID:", "ArticleIdList": ["10.1097/COH.0000000000000472", "PMC6075716", "29782334"]}, {"Citation": "Chia T., Nakamura T., Amano M., Takamune N., Matsuoka M., Nakata H. (2021). A small molecule, ACAi-028, with anti-HIV-1 activity targets a novel hydrophobic pocket on HIV-1 capsid. Antimicrob. Agents Chemother. 65, e01039\u2013e01021. doi: 10.1128/AAC.01039-21", "ArticleIdList": ["10.1128/AAC.01039-21", "PMC8448090", "34228546"]}, {"Citation": "Chun T. W., Carruth L., Finzi D., Shen X., DiGiuseppe J. A., Taylor H., et al. . (1997). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183\u2013188. doi: 10.1038/387183a0", "ArticleIdList": ["10.1038/387183a0", "9144289"]}, {"Citation": "Coelho C., Gallo G., Hardy L., Bottazzi M. E., Campos C., W\u00fcrtele M. (2022). Biochemical screening of potent Zika virus protease inhibitors. ChemMedChem 17:e202100695. doi: 10.1002/cmdc.202100695", "ArticleIdList": ["10.1002/cmdc.202100695", "35104396"]}, {"Citation": "Dom\u00ednguez-Zotes S., Valbuena A., Mateu M. G. (2022). Antiviral compounds modulate elasticity, strength and material fatigue of a virus capsid framework. Biophys. J. 121, 919\u2013931. doi: 10.1016/j.bpj.2022.02.014, PMID:", "ArticleIdList": ["10.1016/j.bpj.2022.02.014", "PMC8943814", "35151634"]}, {"Citation": "Esposito F., Carli I., Del Vecchio C., Xu L., Corona A., Grandi N., et al. . (2016). Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication. Phytomedicine 23, 1383\u20131391. doi: 10.1016/j.phymed.2016.08.001, PMID:", "ArticleIdList": ["10.1016/j.phymed.2016.08.001", "27765358"]}, {"Citation": "Finzi D., Hermankova M., Pierson T., Carruth L. M., Buck C., Chaisson R. E., et al. . (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295\u20131300. doi: 10.1126/science.278.5341.1295, PMID:", "ArticleIdList": ["10.1126/science.278.5341.1295", "9360927"]}, {"Citation": "Freed E. O. (2015). HIV-1 assembly, release and maturation. Nat. Rev. Microbiol. 13, 484\u2013496. doi: 10.1038/nrmicro3490", "ArticleIdList": ["10.1038/nrmicro3490", "PMC6936268", "26119571"]}, {"Citation": "Ganser B. K., Li S., Klishko V. Y., Finch J. T., Sundquist W. I. (1999). Assembly and analysis of conical models for the HIV-1 core. Science 283, 80\u201383. doi: 10.1126/science.283.5398.80", "ArticleIdList": ["10.1126/science.283.5398.80", "9872746"]}, {"Citation": "Grosdidier A., Zoete V., Michielin O. (2011a). SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 39, W270\u2013W277. doi: 10.1093/nar/gkr366, PMID:", "ArticleIdList": ["10.1093/nar/gkr366", "PMC3125772", "21624888"]}, {"Citation": "Grosdidier A., Zoete V., Michielin O. (2011b). Fast docking using the CHARMM force field with EADock DSS. J. Comput. Chem. 32, 2149\u20132159. doi: 10.1002/jcc.21797, PMID:", "ArticleIdList": ["10.1002/jcc.21797", "21541955"]}, {"Citation": "Gross I., Hohenberg H., Wilk T., Wiegers K., Gr\u00e4ttinger M., M\u00fcller B., et al. . (2000). A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19, 103\u2013113. doi: 10.1093/emboj/19.1.103", "ArticleIdList": ["10.1093/emboj/19.1.103", "PMC1171782", "10619849"]}, {"Citation": "Gupta R. K., Abdul-Jawad S., McCoy L. E., Mok H. P., Peppa D., Salgado M., et al. . (2019). HIV-1 remission following CCR5Delta32/Delta32 haematooietic stem-cell transplantation. Nature 568, 244\u2013248. doi: 10.1038/s41586-019-1027-4, PMID:", "ArticleIdList": ["10.1038/s41586-019-1027-4", "PMC7275870", "30836379"]}, {"Citation": "Gupta R. K., Peppa D., Hill A. L., Galvez C., Salgado M., Pace M., et al. . (2020). Evidence for HIV-1 cure after CCR5Delta32/Delta32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report. Lancet HIV 7, e340\u2013e347. doi: 10.1016/S2352-3018(20)30069-2, PMID:", "ArticleIdList": ["10.1016/S2352-3018(20)30069-2", "PMC7606918", "32169158"]}, {"Citation": "H\u00fctter G., Nowak D., Mossner M., Ganepola S., M\u00fcssig A., Allers K., et al. . (2009). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692\u2013698. doi: 10.1056/NEJMoa0802905, PMID:", "ArticleIdList": ["10.1056/NEJMoa0802905", "19213682"]}, {"Citation": "Jacques D. A., McEwan W. A., Hilditch L., Price A. J., Towers G. J., James L. C. (2016). HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis. Nature 536, 349\u2013353. doi: 10.1038/nature19098, PMID:", "ArticleIdList": ["10.1038/nature19098", "PMC4998957", "27509857"]}, {"Citation": "Kobayakawa T., Yokoyama M., Tsuji K., Fujino M., Kurakami M., Boku S., et al. . (2021). Small-molecule anti-HIV-1 agents based on HIV-1 capsid proteins. Biomol. Ther. 11:208. doi: 10.3390/biom11020208, PMID:", "ArticleIdList": ["10.3390/biom11020208", "PMC7913237", "33546092"]}, {"Citation": "Kortagere S., Madani N., Mankowski M. K., Sch\u00f6n A., Zentner I., Swaminathan G., et al. . (2012). Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. J. Virol. 86, 8472\u20138481. doi: 10.1128/JVI.05006-11, PMID:", "ArticleIdList": ["10.1128/JVI.05006-11", "PMC3421734", "22647699"]}, {"Citation": "Lanman J., Sexton J., Sakalian M., Prevelige P. E., Jr. (2002). Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro. J. Virol. 76, 6900\u20136908. doi: 10.1128/JVI.76.14.6900-6908.2002, PMID:", "ArticleIdList": ["10.1128/JVI.76.14.6900-6908.2002", "PMC136311", "12072491"]}, {"Citation": "Le J., Ji H., Zhou X., Wei X., Chen Y., Fu Y., et al. . (2021). Pharmacology, toxicology, and metabolism of sennoside A, A medicinal plant-derived natural compound. Front. Pharmacol. 12:714586. doi: 10.3389/fphar.2021.714586, PMID:", "ArticleIdList": ["10.3389/fphar.2021.714586", "PMC8576406", "34764866"]}, {"Citation": "Lemke C. T., Titolo S., von Schwedler U., Goudreau N., Mercier J.-F., Wardrop E., et al. . (2012). Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. J. Virol. 86, 6643\u20136655. doi: 10.1128/JVI.00493-12, PMID:", "ArticleIdList": ["10.1128/JVI.00493-12", "PMC3393593", "22496222"]}, {"Citation": "Link J. O., Rhee M. S., Tse W. C., Zheng J., Somoza J. R., Rowe W., et al. . (2020). Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature 584, 614\u2013618. doi: 10.1038/s41586-020-2443-1, PMID:", "ArticleIdList": ["10.1038/s41586-020-2443-1", "PMC8188729", "32612233"]}, {"Citation": "Machara A., Lux V., Ko\u017e\u00ed\u0161ek M., Grantz \u0160a\u0161kov\u00e1 K., \u0160t\u011bp\u00e1nek O., Kotora M., et al. . (2016). Specific inhibitors of HIV capsid assembly binding to the C-terminal domain of the capsid protein: evaluation of 2-arylquinazolines as potential antiviral compounds. J. Med. Chem. 59, 545\u2013558. doi: 10.1021/acs.jmedchem.5b01089, PMID:", "ArticleIdList": ["10.1021/acs.jmedchem.5b01089", "26685880"]}, {"Citation": "McFadden W. M., Snyder A. A., Kirby K. A., Tedbury P. R., Raj M., Wang Z., et al. . (2021). Rotten to the core: antivirals targeting the HIV-1 capsid core. Retrovirology 18:41. doi: 10.1186/s12977-021-00583-z, PMID:", "ArticleIdList": ["10.1186/s12977-021-00583-z", "PMC8693499", "34937567"]}, {"Citation": "Momany C., Kovari L. C., Prongay A. J., Keller W., Gitti R. K., Lee B. M., et al. . (1996). Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 3, 763\u2013770. doi: 10.1038/nsb0996-763", "ArticleIdList": ["10.1038/nsb0996-763", "8784350"]}, {"Citation": "Mushtaq A., Kazi F. (2023). Lenacapavir: a new treatment of resistant HIV-1 infections. Lancet Infect. Dis. 23:286. doi: 10.1016/S1473-3099(23)00075-0, PMID:", "ArticleIdList": ["10.1016/S1473-3099(23)00075-0", "36841248"]}, {"Citation": "Pornillos O., Ganser-Pornillos B. K., Banumathi S., Hua Y., Yeager M. (2010). Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus. J. Mol. Biol. 401, 985\u2013995. doi: 10.1016/j.jmb.2010.06.042, PMID:", "ArticleIdList": ["10.1016/j.jmb.2010.06.042", "PMC3050670", "20600115"]}, {"Citation": "Pornillos O., Ganser-Pornillos B. K., Kelly B. N., Hua Y., Whitby F. G., Stout C. D., et al. . (2009). X-ray structures of the hexameric building block of the HIV capsid. Cells 137, 1282\u20131292. doi: 10.1016/j.cell.2009.04.063, PMID:", "ArticleIdList": ["10.1016/j.cell.2009.04.063", "PMC2840706", "19523676"]}, {"Citation": "Price A. J., Jacques D. A., McEwan W. A., Fletcher A. J., Essig S., Chin J. W., et al. . (2014). Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathog. 10:e1004459. doi: 10.1371/journal.ppat.1004459, PMID:", "ArticleIdList": ["10.1371/journal.ppat.1004459", "PMC4214760", "25356722"]}, {"Citation": "Rectenwald J. M., Hardy P. B., Norris-Drouin J. L., Cholensky S. H., James L. I., Frye S. V., et al. . (2019). A general TR-FRET assay platform for high-throughput screening and characterizing inhibitors of methyl-lysine reader proteins. SLAS Discov. 24, 693\u2013700. doi: 10.1177/2472555219844569, PMID:", "ArticleIdList": ["10.1177/2472555219844569", "PMC6586500", "31017815"]}, {"Citation": "Scott D. E., Bayly A. R., Abell C., Skidmore J. (2016). Small molecules, big targets: drug discovery faces the protein\u2013protein interaction challenge. Nat. Rev. Drug Discov. 15, 533\u2013550. doi: 10.1038/nrd.2016.29, PMID:", "ArticleIdList": ["10.1038/nrd.2016.29", "27050677"]}, {"Citation": "Siliciano J. D., Kajdas J., Finzi D., Quinn T. C., Chadwick K., Margolick J. B., et al. . (2003). Long-term followup studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727\u2013728. doi: 10.1038/nm880, PMID:", "ArticleIdList": ["10.1038/nm880", "12754504"]}, {"Citation": "Sticht J., Humbert M., Findlow S., Bodem J., M\u00fcller B., Dietrich U., et al. . (2005). A peptide inhibitor of HIV-1 assembly in vitro. Nat. Struct. Mol. Biol. 12, 671\u2013677. doi: 10.1038/nsmb964", "ArticleIdList": ["10.1038/nsmb964", "16041387"]}, {"Citation": "Sun L., Huang T., Dick A., Meuser M. E., Zalloum W. A., Chen C.-H., et al. . (2020). Design, synthesis and structure-activity relationships of 4-phenyl-1H-1, 2, 3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities. Eur. J. Med. Chem. 190:112085. doi: 10.1016/j.ejmech.2020.112085, PMID:", "ArticleIdList": ["10.1016/j.ejmech.2020.112085", "PMC7053825", "32066010"]}, {"Citation": "Tang C., Loeliger E., Kinde I., Kyere S., Mayo K., Barklis E., et al. . (2003). Antiviral inhibition of the HIV-1 capsid protein. J. Mol. Biol. 327, 1013\u20131020. doi: 10.1016/S0022-2836(03)00289-4", "ArticleIdList": ["10.1016/S0022-2836(03)00289-4", "12662926"]}, {"Citation": "Ternois F., Sticht J., Duquerroy S., Kr\u00e4usslich H. G., Rey F. A. (2005). The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor. Nat. Struct. Mol. Biol. 12, 678\u2013682. doi: 10.1038/nsmb967, PMID:", "ArticleIdList": ["10.1038/nsmb967", "16041386"]}, {"Citation": "Thenin-Houssie S., Valente S. T. (2016). HIV-1 capsid inhibitors as antiretroviral agents. Curr. HIV Res. 14, 270\u2013282. doi: 10.2174/1570162X14999160224103555, PMID:", "ArticleIdList": ["10.2174/1570162X14999160224103555", "PMC4785820", "26957201"]}, {"Citation": "Thenin-Houssier S., De Vera I. M., Pedro-Rosa L., Brady A., Richard A., Konnick B., et al. . (2016). Ebselen, a small-molecule capsid inhibitor of HIV-1 replication. Antimicrob. Agents Chemother. 60, 2195\u20132208. doi: 10.1128/AAC.02574-15, PMID:", "ArticleIdList": ["10.1128/AAC.02574-15", "PMC4808204", "26810656"]}, {"Citation": "Trickey A., May M. T., Vehreschild J. J., Obel N., Gill M. J., Crane H. M., et al. . (2017). Antiretroviral therapy cohort collaboration survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV 4, e349\u2013e356. doi: 10.1016/S2352-3018(17)30066-8, PMID:", "ArticleIdList": ["10.1016/S2352-3018(17)30066-8", "PMC5555438", "28501495"]}, {"Citation": "UNAIDS  (2021). Global HIV & AIDS statistics \u2014 Fact sheet. UNAIDS DATA 2021. Available at: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_ FactSheet_en.pdf"}, {"Citation": "Wong J. K., Hezareh M., G\u00fcnthard H. F., Havlir D. V., Ignacio C. C., Spina C. A., et al. . (1997). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291\u20131295. doi: 10.1126/science.278.5341.1291, PMID:", "ArticleIdList": ["10.1126/science.278.5341.1291", "9360926"]}, {"Citation": "Xu J. P., Branson J. D., Lawrence R., Cocklin S. (2016). Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer. Bioorg. Med. Chem. Lett. 26, 824\u2013828. doi: 10.1016/j.bmcl.2015.12.087, PMID:", "ArticleIdList": ["10.1016/j.bmcl.2015.12.087", "PMC4728034", "26747394"]}, {"Citation": "Xu J. P., Francis A. C., Meuser M. E., Mankowski M., Ptak R. G., Rashad A. A., et al. . (2018). Exploring modifications of an HIV-1 capsid inhibitor: design, synthesis, and mechanism of action. J. Drug Des. Res. 5:1070.", "ArticleIdList": ["PMC6214487", "30393786"]}, {"Citation": "Zhang X. (2018). Anti-retroviral drugs: current state and development in the next decade. Acta Pharm. Sin. B 8, 131\u2013136. doi: 10.1016/j.apsb.2018.01.012, PMID:", "ArticleIdList": ["10.1016/j.apsb.2018.01.012", "PMC5925449", "29719774"]}, {"Citation": "Zhang J. H., Chung T. D., Oldenburg K. R. (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67\u201373. doi: 10.1177/108705719900400206, PMID:", "ArticleIdList": ["10.1177/108705719900400206", "10838414"]}, {"Citation": "Zhang H., Curreli F., Waheed A. A., Mercredi P. Y., Mehta M., Bhargava P., et al. . (2013). Dual-acting stapled peptides target both HIV-1 entry and assembly. Retrovirology 10, 1\u201320. doi: 10.1186/1742-4690-10-136", "ArticleIdList": ["10.1186/1742-4690-10-136", "PMC3842668", "24237936"]}, {"Citation": "Zhang H., Curreli F., Zhang X., Bhattacharya S., Waheed A. A., Cooper A., et al. . (2011). Antiviral activity of \u03b1-helical stapled peptides designed from the HIV-1 capsid dimerization domain. Retrovirology 8, 1\u201318. doi: 10.1186/1742-4690-8-28", "ArticleIdList": ["10.1186/1742-4690-8-28", "PMC3097154", "21539734"]}, {"Citation": "Zhang D. W., Luo R. H., Xu L., Yang L. M., Xu X. S., Bedwell G. J., et al. . (2019). A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-terminal domain of capsid. Antivir. Res. 169:104544. doi: 10.1016/j.antiviral.2019.104544, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2019.104544", "PMC6901019", "31254557"]}, {"Citation": "Zhang D. W., Luo R. H., Xu L., Yang L. M., Xu X. S., Zheng Y. T., et al. . (2020). Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors. Int. J. Antimicrob. Agents 55:105926. doi: 10.1016/j.ijantimicag.2020.105926, PMID:", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105926", "32092396"]}, {"Citation": "Zhang D. W., Xie L. X., Xu X. S., Li Y. M., Xu X. J. (2023). A broad-spectrum antiviral molecule, protoporphyrin IX, acts as a moderator of HIV-1 capsid assembly by targeting the capsid hexamer. Microbiol. Spectr. 11:e0266322. doi: 10.1128/spectrum.02663-22, PMID:", "ArticleIdList": ["10.1128/spectrum.02663-22", "PMC9927277", "36475726"]}, {"Citation": "Zhang H., Zhao Q., Bhattacharya S., Waheed A. A., Tong X., Hong A., et al. . (2008). A cell-penetrating helical peptide as a potential HIV-1 inhibitor. J. Mol. Biol. 378, 565\u2013580. doi: 10.1016/j.jmb.2008.02.066, PMID:", "ArticleIdList": ["10.1016/j.jmb.2008.02.066", "PMC2695608", "18374356"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "31"}, {"Year": "2023", "Month": "9", "Day": "11"}, {"Year": "2023", "Month": "10", "Day": "11", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "10", "Day": "11", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "10", "Day": "11", "Hour": "3", "Minute": "44"}, {"Year": "2023", "Month": "9", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["37817748", "PMC10561090", "10.3389/fmicb.2023.1270258"]}}], "PubmedBookArticle": []}